In addition, as we have explained above, Bank Indonesia in 2022 also supported APBN financing of Rp142.35 trillion, consisting of the purchase of SBN from the primary market based on the joint decree I (KB-I) mechanism of Rp46.93 trillion and joint decree III (KB-III) of Rp95.42 trillion, until 15 November 2022.
The continued purchase of SBN from the primary market in 2022 demonstrates Bank Indonesia’s strong commitment in supporting APBN funding, both in terms of health and humanitarian financing due to the impact of the Covid-19 pandemic, and accelerating national economic recovery.